81 related articles for article (PubMed ID: 11873519)
1. Inhibition of adjuvant-induced arthritis by 16 alpha-fluoro-5-androsten-17-one.
Schwartz AG; Pashko LL
Mil Med; 2002 Feb; 167(2 Suppl):60-3. PubMed ID: 11873519
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of rat prostate carcinogenesis by dietary 16alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone.
McCormick DL; Johnson WD; Kozub NM; Rao KV; Lubet RA; Steele VE; Bosland MC
Carcinogenesis; 2007 Feb; 28(2):398-403. PubMed ID: 16952912
[TBL] [Abstract][Full Text] [Related]
3. Novel dehydroepiandrosterone analogues with enhanced biological activity and reduced side effects in mice and rats.
Schwartz AG; Lewbart ML; Pashko LL
Cancer Res; 1988 Sep; 48(17):4817-22. PubMed ID: 2970293
[TBL] [Abstract][Full Text] [Related]
4. A synthetic androstene analogue inhibits collagen-induced arthritis in the mouse.
Offner H; Zamora A; Subramanian S; Polanczyk M; Krogstad A; Auci DL; Morgan EE; Reading CL
Clin Immunol; 2004 Feb; 110(2):181-90. PubMed ID: 15003815
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of carcinogen-activating enzymes by 16alpha-fluoro-5-androsten-17-one.
Ciolino HP; MacDonald CJ; Yeh GC
Cancer Res; 2002 Jul; 62(13):3685-90. PubMed ID: 12097275
[TBL] [Abstract][Full Text] [Related]
6. Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs.
Schwartz AG; Pashko LL
J Cell Biochem Suppl; 1995; 22():210-7. PubMed ID: 8538200
[TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replication.
Henderson E; Yang JY; Schwartz A
AIDS Res Hum Retroviruses; 1992 May; 8(5):625-31. PubMed ID: 1381206
[TBL] [Abstract][Full Text] [Related]
8. Identification of [14C]fluasterone metabolites in urine and feces collected from dogs after subcutaneous and oral administration of [14C]fluasterone.
Burgess JP; Green JS; Hill JM; Zhan Q; Lindeblad M; Lyubimov A; Kapetanovic IM; Schwartz A; Thomas BF
Drug Metab Dispos; 2009 May; 37(5):1089-97. PubMed ID: 19196848
[TBL] [Abstract][Full Text] [Related]
9. A new orally bioavailable synthetic androstene inhibits collagen-induced arthritis in the mouse: androstene hormones as regulators of regulatory T cells.
Auci D; Kaler L; Subramanian S; Huang Y; Frincke J; Reading C; Offner H
Ann N Y Acad Sci; 2007 Sep; 1110():630-40. PubMed ID: 17911478
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16alpha-fluoro-5-androsten-17-one.
Perkins SN; Hursting SD; Haines DC; James SJ; Miller BJ; Phang JM
Carcinogenesis; 1997 May; 18(5):989-94. PubMed ID: 9163685
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
[TBL] [Abstract][Full Text] [Related]
13. Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis rats.
Tan XD; Dou YC; Shi CW; Duan RS; Sun RP
J Neuroimmunol; 2009 Feb; 207(1-2):39-44. PubMed ID: 19174309
[TBL] [Abstract][Full Text] [Related]
14. 7-Hydroxy androstene steroids and a novel synthetic analogue with reduced side effects as a potential agent to treat autoimmune diseases.
Auci DL; Reading CL; Frincke JM
Autoimmun Rev; 2009 Mar; 8(5):369-72. PubMed ID: 19071234
[TBL] [Abstract][Full Text] [Related]
15. An orally bioavailable synthetic analog of an active dehydroepiandrosterone metabolite reduces established disease in rodent models of rheumatoid arthritis.
Offner H; Firestein GS; Boyle DL; Pieters R; Frincke JM; Garsd A; White SK; Reading CL; Auci DL
J Pharmacol Exp Ther; 2009 Jun; 329(3):1100-9. PubMed ID: 19297421
[TBL] [Abstract][Full Text] [Related]
16. Improvement of spontaneous locomotor activity with JAK inhibition by JTE-052 in rat adjuvant-induced arthritis.
Tanimoto A; Shinozaki Y; Nozawa K; Kimoto Y; Amano W; Matsuo A; Yamaguchi T; Matsushita M
BMC Musculoskelet Disord; 2015 Nov; 16():339. PubMed ID: 26546348
[TBL] [Abstract][Full Text] [Related]
17. [Effect of dehydroepiandrosterone on cellular immune response in experimental autoimmune neuritis in Lewis rats].
Tan XD; Duan RS; Shi CW; Qu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):760-3. PubMed ID: 20104686
[TBL] [Abstract][Full Text] [Related]
18. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.
Koufany M; Jouzeau JY; Moulin D
Biomed Mater Eng; 2014; 24(1 Suppl):81-8. PubMed ID: 24928921
[TBL] [Abstract][Full Text] [Related]
19. Antihyperglycemic effect of dehydroepiandrosterone analogue 16 alpha-fluoro-5-androsten-17-one in diabetic mice.
Pashko LL; Schwartz AG
Diabetes; 1993 Aug; 42(8):1105-8. PubMed ID: 8325440
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of murine antigen-induced arthritis by dehydroepiandrosterone (DHEA).
Röntzsch A; Thoss K; Petrow PK; Henzgen S; Bräuer R
Inflamm Res; 2004 May; 53(5):189-98. PubMed ID: 15105968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
